Fundamental analysis by سیگنال و تحلیل سهام | بورسکده | about Stock دالبر on 6/10/2025

Estimation of Profitability of #Dalber * Company has changed the fiscal year to December Estimated Profit 1404: 937 Rials Ratio P/E Forward: 4 With estimated assumptions and profit and 4 -unit P/E ratio of current prices and with 5.4 as a marketer is an attractive market investment option. Tip 1: The Company is exploiting the Cephalosporin Development Plan this year, which is not considered as an estimated profit. Tip 2: The company also identifies non -operational profits from Alborz Broadcasting Sale, which is not included in the estimated profit. Tip 3: The profitability growth of the company is due to the increase in high rates in injectable products, the government's view of supportive injectable products and the implementation of good rates. Javad Abdullahi